TARUNENDU DWIVEDI: Open Payments
NPI 1063481844 · ROCK HILL, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 21 payments from 11 companies in 2025. Trend: 2023 $71 · 2024 $648 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $236 |
| Janssen Pharmaceuticals, Inc | 1 | $118 |
| Tris Pharma Inc | 2 | $47 |
| Supernus Pharmaceuticals, Inc. | 1 | $34 |
| Neos Therapeutics, LP | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: VRAYLAR, SPRAVATO, Dyanavel XR, Qelbree, Adzenys XR-ODT, Auvelity, INGREZZA, COBENFY.
Industry payments across SC — which companies pay providers there.
